COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 59: Articles 581-590  | Next

Allosteric Control and Glycan Shielding Adaptations in the SARS-CoV-2 Spike from Early to Peak Virulence
Chakraborty, S., Nguyen, K. N., Zhao, M., Gnanakaran, S.
10.1101/2025.03.11.642723 — Posted: 2025-03-12
Informing antiviral effectiveness for influenza A andSARS-CoV-2 by quantifying within-host interaction betweentransmission and immunity
Gokhale, D., Criado, M. F., Rowe, D. K., Tomkins, S. M., Rohani, P.
10.1101/2025.03.11.642706 — Posted: 2025-03-12
D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes
Kearns, F., Bogetti, A., Calvo-Tussell, C., Braza, M. K., Casalino, L., Gramm, A. J., Braet, S. M., Rosenfeld, M., Rajapaksha, H., Barker, B., Anand, G. S., Chong, L., Ahn, S.-H., Amaro, R. E.
10.1101/2025.03.07.642081 — Posted: 2025-03-11
Sustainability of Evidence-Based Practice Improvement Programs in Abu Dhabi Ambulatory Healthcare Services for more than a decade and During the COVID-19 Pandemic
Baynouna Alketbi, L. M., Nagelkerke, N., Abdelbaqi, H.
10.1101/2025.03.11.25323728 — Posted: 2025-03-11
Multiplexed Salivary miRNA Quantification for Predicting Severe COVID-19 Symptoms in Children Using Ligation-RPA Amplification Assay
Ahamed, M. A., Zhang, Z., Kshirsagar, A., Politza, A. J., Sethuraman, U., Suresh, S., Hicks, S., Guo, F., Guan, W.
10.1101/2025.03.10.25323665 — Posted: 2025-03-11
Long-Term Persistence and Recovery of Short-Term Memory Loss in COVID-19 Survivors: A 3.5-Year Follow-Up Study
Jha, R. K., Narayan, R. K., Paikra, S. K., Ghosh, S. K., Kirti, R., Rai, D. K., Banerjee, A., Sarfaraz, A., Kumar, A.
10.1101/2025.03.10.25323656 — Posted: 2025-03-11
Association between Covid-19 BNT162b2 vaccination or SARS-CoV-2 infection and immune mediated diseases in 5 million 5-to-19-year-olds in four Nordic countries
Tapia, G., Ljung, R., Thiesson, E. M., Pihlstrom, N., Nieminen, T., Bakken, I. J., Gulseth, H., Nohynek, H., Karlstad, O., Hviid, A.
10.1101/2025.03.09.25323620 — Posted: 2025-03-11
The furin cleavage site is required for pathogenesis, but not transmission of SARS-CoV-2
Morgan, A. L., Vu, M. N., Zhou, Y., Lokugamage, K. G., Meyers, W., Alvarado, R. E., Ahearn, Y. P., Estes, L. K., Plante, J. A., Johnson, B. A., Suthar, M., Walker, D. H., Plante, K. S., Menachery, V. D.
10.1101/2025.03.10.642264 — Posted: 2025-03-11
Unveiling the Immune Landscape of COVID-19 and prolonged Long-COVID through Single-Cell RNA Sequencing
Springe, M. L., Vaivode, K., Saksis, R., Vainselbauma, N. M., Ansone, L., Briviba, M., Niedra, H., Rovite, V.
10.1101/2025.03.05.641671 — Posted: 2025-03-11
The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication
Al Krad, D., Stegmann, K. M., Dickmanns, A., Blaurock, C., Mohl, B.-P., Wille, S. J., Breithaupt, A., Britzke, T., Balkema-Buschmann, A., Dobbelstein, M.
10.1101/2025.03.09.642200 — Posted: 2025-03-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).